Performed with the Dilon 6800 Gamma Camera, Breast-Specific Gamma Imaging (BSGI) - sometimes called Molecular Breast Imaging - is an excellent problem-solving tool for questionable findings on mammography or breast ultrasound. It can also be helpful for evaluating areas of palpable concern when the mammogram and ultrasound are normal. This molecular imaging technique has a high sensitivity for the early detection of breast cancer with infrequent false-positive results.  Because the interpretation of BSGI is not affected by breast tissue density, it is an ideal diagnostic complement to mammography. Medicare and most private insurance companies cover BSGI under standard nuclear breast imaging codes. In May 2007, Weinstein Imaging Associates became the first facility in western Pennsylvania and the entire Pittsburgh tri-state region to offer this service.     Click on images to view the rest of the Dilon brochure on BSGI

Comparison of Breast Imaging Modalities

Key: Low - less than 40%, Medium - 40 to 80%, High - greater than 80%, Variable - referenced range varies by more than 30%.

Radiology Today magazine article about the role of BSGI and PEM (positron emission mammography) in breast cancer detection.
The Breast Journal article showing that BSGI and MRI have similar sensitivities, but BSGI has higher specificity than MRI.
Academic Radiology article showing that BSGI has better sensitivity than MRI or mammography for detecting ductal carcinoma in situ (DCIS).
Our press release about BSGI, which includes photos and video clips of this new test.
Various media articles about our role in introducing BSGI to the Pittsburgh region.
April 2008 article showing that BSGI found breast cancer in 2% of women with normal mammograms.
Radio ad on KDKA-AM featuring BSGI usage in our practice.
Additional information is also available on Dilon's web site.